Related references
Note: Only part of the references are listed.PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential
Wei-Jong Shia et al.
BLOOD (2012)
ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia
Joost H. A. Martens et al.
BLOOD (2012)
An integrated ChIP-seq analysis platform with customizable workflows
Eugenia G. Giannopoulou et al.
BMC BIOINFORMATICS (2011)
The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation
Lan Wang et al.
SCIENCE (2011)
RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis
Ming Yan et al.
BLOOD (2009)
Structure of the AML1-ETO eTAFH domain-HEB peptide complex and its contribution to AML1-ETO activity
Sangho Park et al.
BLOOD (2009)
Exhaustive Search for Over-represented DNA Sequence Motifs with CisFinder
Alexei A. Sharov et al.
DNA RESEARCH (2009)
Mouse models of human AML accurately predict chemotherapy response
Johannes Zuber et al.
GENES & DEVELOPMENT (2009)
Multivalent Binding of the ETO Corepressor to E Proteins Facilitates Dual Repression Controls Targeting Chromatin and the Basal Transcription Machinery
Chun Guo et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Transforming activity of AML1-ETO is independent of CBFβ and ETO interaction but requires formation of homo-oligomeric complexes
Colin Kwok et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
t(8;21)(q22;q22) fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression
Akiko J. Okumura et al.
BLOOD (2008)
An integrated software system for analyzing ChIP-chip and ChIP-seq data
Hongkai Ji et al.
NATURE BIOTECHNOLOGY (2008)
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Ali Mortazavi et al.
NATURE METHODS (2008)
Choose your partners: dimerization in eukaryotic transcription factors
Grigoris D. Amoutzias et al.
TRENDS IN BIOCHEMICAL SCIENCES (2008)
AML1/ETO Oncoprotein Is Directed to AML1 Binding Regions and Co-Localizes with AML1 and HEB on Its Targets
Alessandro Gardini et al.
PLOS GENETICS (2008)
PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis
Gang Huang et al.
NATURE GENETICS (2008)
A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis
Ming Yan et al.
NATURE MEDICINE (2006)
The tetramer structure of the Nervy homology two domain, NHR2, is critical for AM1/ETO's activity
YZ Liu et al.
CANCER CELL (2006)
E protein silencing by the leukemogenic AML1-ETO fusion protein
JS Zhang et al.
SCIENCE (2004)
The 8; 21 translocation in leukemogenesis
LF Peterson et al.
ONCOGENE (2004)
Epigenetic consequences of AML1-ETO action at the human c-FMS locus
GA Follows et al.
EMBO JOURNAL (2003)
RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation
KE Elagib et al.
BLOOD (2003)
AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells
O Heidenreich et al.
BLOOD (2003)
The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells
JC Mulloy et al.
BLOOD (2002)
Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation
S Minucci et al.
MOLECULAR CELL (2000)
Share Paper
